LSLF





 


FUNDED GRANTS 1990 - 1995

1995
Michael Gilman, PhD
Cold Spring Harbor Laboratory, Cold Spring Harbor,NY
Controlling Cell Growth in Lymphoid CLL
Grant made possible by The Ambassador Felix Schnyder Fund
In memory of Ambassador Felix Schnyder


Elizabeth A. McGuire, MD
University of Pittsburgh Medical Center
Cancer Institute, Pittsburgh, PA

Functional Characterization of Ttgl, a LIM Domain of Oncogene in T-ALL

Michael W. Schuster, MD
New York Weill Cornell Center, New York, NY
Research Undertaken at North Shore University Hospital, Manhasset, NY
Purging Bone Marrow With Magnetic Beads
in Autologous BHT

Grant made possible by The Ambassador Felix Schnyder Fund
In memory of Ambassador Felix Schnyder


Richard Steinman, MD, PhD
University of Pittsburgh Medical Center
Cancer Institute, Pittsburgh, PA

The Role of p21 (WAF-1) to Hematopoietic Differential

1994
Stephen D. Hassenfeld Children’s Center for Cancer and Blood Disorders
New York University Medical Center, NY, NY

Continuation of 1993 Grant
In honor of Adam Schwartz


Ursula Matulonis, MD
Harvard Medical School
Dana-Farber Cancer Institute, Boston, MA

Therapies to Block the Interaction of BCR-ABL with Proteins in CML Cell Growth

David A. Scheinberg, MD, PhD
Memorial Sloan-Kettering Cancer Center,
NY, NY
Monoclonal Antibodies in Patients with ‘APL’

1993
Stephen D. Hassenfeld Children’s Center for Cancer and Blood Disorders
New York University Medical Center,
NY, NY

These funds were applied in part to support
psycho-social services rendered to children with leukemia and other forms of cancer and their families, as well as to enable underinsured or uninsured children to receive optimal medical care at the Center.

In honor of Adam Schwartz

Florence Ajchenbaum, MD
Dana-Farber Cancer Institute, Boston, MA
Cancer Associated Genes’ Ability to Control Growth and Their Role in the Development of Leukemias

Steven Nimer, MD
Memorial Sloan-Kettering Center, NY, NY
Molecular Targets to Develop Novel and Specific Methods of Diagnosing and Treating Acute Leukemia

1992
Verena Bier, MD
University of Heidelberg, Visiting Fogarty Fellow, National Cancer Institute,
Bethesda, MD

Gene Development and Cell Growth as They
Relate to the Formation of Leukemia


Kanti Rai, MD
Long Island Jewish Medical Center,
New Hyde Park, NY

Evaluation of New Drugs in CLL Continuation
of 1990 Grant


1991
Robert J. Fallon, MD, PhD
Riley Children’s Hospital, Indiana University
School of Medicine, Indianapolis, IN

Cell Related Abnormalities Occurring in
Early Stages of Cancer
Research undertaken at Pediatric Hematology/Oncology
and Stem Cell Transplants, Cardinal Glennon
Children’s Hospital, St. Louis School of Medicine, St. Louis, MO


Kanti R. Rai, MD
Long Island Jewish Medical Center,
New Hyde Park, NY

The Study of Chronic Lymphocytic Leukemia,
Including Evaluation of New Drugs


1990
Loren Walensky, MD
Resident, Children’s Hospital Medical Center
Boston, MA

Study undertaken at Princeton University
mentored by Professor Taylor - Research as a Summer

Fellow in Chemotherapeutic Development

Sujata Rao, MD
Fred Hutchinson Cancer Center, Seattle, WA
Research undertaken at Memorial Sloan-Kettering Cancer Center, NY, NY

Purging in Bone Marrow Transplantation


1   2   3   4   5   6   7

LSLF

Lauri  Strauss Leukemia Foundation
30 Park Avenue • Suite 11F • New York, NY 10016
Telephone: 212-696-1033 • Fax: 212-689-1622 • Email:lslf@aol.com